Amyloid burden and neural function in people at risk for Alzheimer's Disease
暂无分享,去创建一个
Sterling C. Johnson | Barbara B. Bendlin | Bradley T. Christian | Mark A. Sager | Ozioma C. Okonkwo | N. Maritza Dowling | William E. Klunk | Chester A. Mathis | Dhanabalan Murali | Guofan Xu | Cynthia M. Carlsson | Sanjay Asthana | Howard A. Rowley | Dustin W. Wooten | Ansel T. Hillmer | Todd E. Barnhart | Bruce P. Hermann | Catherine L. Gallagher | W. Klunk | C. Mathis | O. Okonkwo | B. Christian | H. Rowley | B. Hermann | B. Bendlin | S. Asthana | C. Carlsson | M. Sager | Guofan Xu | T. Barnhart | Jennifer M Oh | N. M. Dowling | C. Gallagher | A. Hillmer | D. Wooten | D. Murali | L. Hall | A. Racine | Sandra J. Harding | Sandra Harding | Annie M. Racine | Jennifer M. Oh | Lance T. Hall | B. Christian | S. Johnson | B. Hermann | S. Harding | Sandra Harding | Bruce P. Hermann
[1] Sterling C. Johnson,et al. Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults , 2012, Neurology.
[2] P. Scheltens,et al. Brain imaging and Alzheimer's disease , 1993, European Neuropsychopharmacology.
[3] C. Jack,et al. An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease , 2012, Annals of neurology.
[4] Cindee M. Madison,et al. Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly , 2014, Human brain mapping.
[5] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[6] John X. Morris,et al. Increased risk of dementia in mothers of Alzheimer's disease cases , 1996, Neurology.
[7] Gaël Chételat,et al. Alzheimer disease: Aβ-independent processes—rethinking preclinical AD , 2013, Nature Reviews Neurology.
[8] R. Clark,et al. The medial temporal lobe. , 2004, Annual review of neuroscience.
[9] Sterling C. Johnson,et al. Effect of parental family history of Alzheimer's disease on serial position profiles , 2008, Alzheimer's & Dementia.
[10] Rachel L. Mistur,et al. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism , 2007, Proceedings of the National Academy of Sciences.
[11] Karl J. Friston,et al. Voxel-Based Morphometry—The Methods , 2000, NeuroImage.
[12] Vijaya L. Melnick,et al. Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.
[13] J. Jolles,et al. Functional integration of parietal lobe activity in early Alzheimer disease , 2012, Neurology.
[14] Bedda L. Rosario,et al. Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve , 2009, The Journal of Neuroscience.
[15] D. Balota,et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. , 2011, Archives of neurology.
[16] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[17] Lewis H Kuller,et al. In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects , 2013, Annals of neurology.
[18] R. Swerdlow,et al. Brain aging, Alzheimer's disease, and mitochondria. , 2011, Biochimica et biophysica acta.
[19] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[21] Rachel L. Mistur,et al. Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease , 2009, Neurology.
[22] C. Rowe,et al. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults , 2012, Neurology.
[23] Keith A. Johnson,et al. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease , 2013, Neurobiology of Aging.
[24] J. Hardy,et al. Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.
[25] S. de Santi,et al. Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer’s , 2010, Proceedings of the National Academy of Sciences.
[26] J. Gunter,et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease , 2012, Neurology.
[27] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .
[28] Sterling C. Johnson,et al. White matter is altered with parental family history of Alzheimer's disease , 2010, Alzheimer's & Dementia.
[29] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[30] Keith A. Johnson,et al. Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals , 2013, Neurobiology of Aging.
[31] C. Jack,et al. Comparison of 18F-FDG and PiB PET in Cognitive Impairment , 2009, Journal of Nuclear Medicine.
[32] M. Gatz,et al. The Alzheimer's disease knowledge test. , 1988, The Gerontologist.
[33] S. Vallabhajosula,et al. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents , 2013, Neurobiology of Aging.
[34] A. Furst,et al. Amyloid-β and glucose metabolism in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[35] M. Albert,et al. Medial temporal lobe function and structure in mild cognitive impairment , 2004, Annals of neurology.
[36] C. Jack,et al. Evidence for ordering of Alzheimer disease biomarkers. , 2011, Archives of neurology.
[37] W. Jagust,et al. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core , 2010, Alzheimer's & Dementia.
[38] Kewei Chen,et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.
[39] C. Jack,et al. Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis. , 2013, JAMA neurology.
[40] B. Kolachana,et al. Interactive effect of apolipoprotein e genotype and age on hippocampal activation during memory processing in healthy adults. , 2012, Archives of general psychiatry.
[41] S. DeKosky,et al. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] C. Rowe,et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.
[43] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[44] M. Mintun,et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline , 2012, Annals of neurology.
[45] Nick C. Fox,et al. Ten simple rules for reporting voxel-based morphometry studies , 2008, NeuroImage.
[46] B. Hermann,et al. Middle-Aged Children of Persons With Alzheimer’s Disease: APOE Genotypes and Cognitive Function in the Wisconsin Registry for Alzheimer’s Prevention , 2005, Journal of geriatric psychiatry and neurology.
[47] Charles A Mistretta,et al. Improved kinetic analysis of dynamic PET data with optimized HYPR-LR. , 2012, Medical physics.
[48] R. Petersen,et al. Mild cognitive impairment , 2006, The Lancet.
[49] Núria Jolis Orriols,et al. The Alzheimer’s disease : , 2015 .
[50] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[51] Olivier Salvado,et al. Larger temporal volume in elderly with high versus low beta-amyloid deposition. , 2010, Brain : a journal of neurology.
[52] Francis Eustache,et al. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease , 2013, NeuroImage: Clinical.
[53] K. Worsley,et al. Unified univariate and multivariate random field theory , 2004, NeuroImage.
[54] Alan A. Wilson,et al. Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. , 2000, Nuclear medicine and biology.
[55] Paul J. Laurienti,et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.
[56] Matthew L Senjem,et al. Indicators of amyloid burden in a population-based study of cognitively normal elderly , 2012, Neurology.
[57] M. Albert,et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[58] A. Hebrank,et al. Beta-amyloid burden alters Default Mode and Salience Network connectivity related to impaired cognition in healthy adults , 2012 .
[59] R. Honea,et al. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease , 2010, Neurology.
[60] A. Fagan,et al. APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.
[61] Denise C. Park,et al. &bgr;-Amyloid burden in healthy aging: Regional distribution and cognitive consequences , 2012, Neurology.
[62] W. Jagust,et al. Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.
[63] Sterling C. Johnson,et al. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. , 2014, Cerebral cortex.
[64] Charles A Mistretta,et al. Dynamic PET Denoising with HYPR Processing , 2010, Journal of Nuclear Medicine.
[65] Nick C Fox,et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.
[66] L. Mucke,et al. Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.
[67] R. Honea,et al. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease , 2011, Neurology.